D2R Investor Series with Inès Holzbaur скачать в хорошем качестве

D2R Investor Series with Inès Holzbaur

Every year, billions of dollars are invested by funding agencies in basic and translational research, yet the path from academic discovery to private investment necessary for the creation of new companies is rarely straightforward. In this seminar, Inès Holzbaur, Founder and Managing Partner of AmorChem, provides an inside look at how investors work, what makes a research idea stand out to venture capitalists, and how they evaluate translational value of scientific opportunities. This session demystifies the framework needed to transition an idea or mechanism discovered in the lab to an investment phase. --------------- D2R (DNA to RNA) is a research initiative at McGill that is positioning Canada as a global leader in RNA-based therapies, revolutionizing treatments for rare and infectious diseases, and cancer. With a landmark $165 million investment from the Government of Canada, D2R is advancing cutting-edge science and building powerful collaborations across academia, industry, and different communities to ensure that life-saving therapies are accessible to all, especially equity-deserving populations. --------------- WEBSITE: https://www.mcgill.ca/dna-to-rna/ TWITTER/X: https://x.com/D2RMcGill BLUESKY: https://bsky.app/profile/d2rmcgill.bs... LINKED IN:   / d2r-dna-to-rna